Cite
Le Pechoux C, Pourel N, Barlesi F, et al. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial. Lancet Oncol. 2021;doi: 10.1016/S1470-2045(21)00606-9.
Le Pechoux, C., Pourel, N., Barlesi, F., Lerouge, D., Antoni, D., Lamezec, B., Nestle, U., Boisselier, P., Dansin, E., Paumier, A., Peignaux, K., Thillays, F., Zalcman, G., Madelaine, J., Pichon, E., Larrouy, A., Lavole, A., Argo-Leignel, D., Derollez, M., Faivre-Finn, C., Hatton, M. Q., Riesterer, O., Bouvier-Morel, E., Dunant, A., Edwards, J. G., Thomas, P. A., Mercier, O., & Bardet, A. (2021). Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial. The Lancet. Oncology, . https://doi.org/10.1016/S1470-2045(21)00606-9
Le Pechoux, Cecile, et al. "Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial." The Lancet. Oncology vol. (2021). doi: https://doi.org/10.1016/S1470-2045(21)00606-9
Le Pechoux C, Pourel N, Barlesi F, Lerouge D, Antoni D, Lamezec B, Nestle U, Boisselier P, Dansin E, Paumier A, Peignaux K, Thillays F, Zalcman G, Madelaine J, Pichon E, Larrouy A, Lavole A, Argo-Leignel D, Derollez M, Faivre-Finn C, Hatton MQ, Riesterer O, Bouvier-Morel E, Dunant A, Edwards JG, Thomas PA, Mercier O, Bardet A. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial. Lancet Oncol. 2021 Dec 14; doi: 10.1016/S1470-2045(21)00606-9. Epub 2021 Dec 14. PMID: 34919827.
Copy
Download .nbib